239 related articles for article (PubMed ID: 10958223)
1. Hepatocellular carcinoma in Austria: aetiological and clinical characteristics at presentation.
Schöniger-Hekele M; Müller C; Kutilek M; Oesterreicher C; Ferenci P; Gangl A
Eur J Gastroenterol Hepatol; 2000 Aug; 12(8):941-8. PubMed ID: 10958223
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.
Ozer B; Serin E; Yilmaz U; Gümürdülü Y; Saygili OB; Kayaselçuk F; Boyacioğlu S
Turk J Gastroenterol; 2003 Jun; 14(2):85-90. PubMed ID: 14614632
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low-endemic area.
Kubicka S; Rudolph KL; Hanke M; Tietze MK; Tillmann HL; Trautwein C; Manns M
Liver; 2000 Jul; 20(4):312-8. PubMed ID: 10959810
[TBL] [Abstract][Full Text] [Related]
4. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D
Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors of survival in patients with non-resectable hepatocellular carcinoma: hepatitis C versus miscellaneous etiology.
Abbas Z; Siddiqui AU; Luck NH; Hassan M; Mirza R; Naqvi A; Rizvi AH
J Pak Med Assoc; 2008 Nov; 58(11):602-7. PubMed ID: 19024130
[TBL] [Abstract][Full Text] [Related]
6. Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.
Janjua NZ; Chong M; Kuo M; Woods R; Wong J; Yoshida EM; Sherman M; Butt ZA; Samji H; Cook D; Yu A; Alvarez M; Tyndall M; Krajden M
J Hepatol; 2017 Mar; 66(3):504-513. PubMed ID: 27818234
[TBL] [Abstract][Full Text] [Related]
7. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.
Lu SN; Wang JH; Liu SL; Hung CH; Chen CH; Tung HD; Chen TM; Huang WS; Lee CM; Chen CC; Changchien CS
Cancer; 2006 Nov; 107(9):2212-22. PubMed ID: 17019738
[TBL] [Abstract][Full Text] [Related]
8. Incidence and Risk Factors for Hepatocellular Carcinoma in Cirrhosis: The Multicenter Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study.
Reddy KR; McLerran D; Marsh T; Parikh N; Roberts LR; Schwartz M; Nguyen MH; Befeler A; Page-Lester S; Tang R; Srivastava S; Rinaudo JA; Feng Z; Marrero JA
Gastroenterology; 2023 Oct; 165(4):1053-1063.e6. PubMed ID: 37429366
[TBL] [Abstract][Full Text] [Related]
9. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of a large cohort of patients with hepatocellular carcinoma in a single European centre.
Herold C; Reck T; Fischler P; Ott R; Radespiel-Troeger M; Ganslmayer M; Hohenberger W; Hahn EG; Schuppan D
Liver; 2002 Feb; 22(1):23-8. PubMed ID: 11906615
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of chronic hepatitis C patients related to baseline liver fibrosis stage: a hospital-based linkage study.
Huang Y; de Boer WB; Adams LA; MacQuillan G; Bulsara MK; Jeffrey GP
Intern Med J; 2015 Jan; 45(1):48-54. PubMed ID: 25371273
[TBL] [Abstract][Full Text] [Related]
12. Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis.
Ganne-Carrié N; Chaffaut C; Bourcier V; Archambeaud I; Perarnau JM; Oberti F; Roulot D; Moreno C; Louvet A; Dao T; Moirand R; Goria O; Nguyen-Khac E; Carbonell N; Antonini T; Pol S; de Ledinghen V; Ozenne V; Henrion J; Péron JM; Tran A; Perlemuter G; Amiot X; Zarski JP; Beaugrand M; Chevret S;
J Hepatol; 2018 Dec; 69(6):1274-1283. PubMed ID: 30092234
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma: an emerging problem with hepatitis C.
Jeffers L
J Natl Med Assoc; 2000 Aug; 92(8):369-71. PubMed ID: 10992680
[TBL] [Abstract][Full Text] [Related]
14. Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis.
Colapietro F; Maisonneuve P; Lytvyak E; Beuers U; Verdonk RC; van der Meer AJ; van Hoek B; Kuiken SD; Brouwer JT; Muratori P; Aghemo A; Carella F; van den Berg AP; Zachou K; Dalekos GN; Di Zeo-Sánchez DE; Robles M; Andrade RJ; Montano-Loza AJ; van den Brand FF; Slooter CD; Macedo G; Liberal R; de Boer YS; Lleo A; ;
J Hepatol; 2024 Jan; 80(1):53-61. PubMed ID: 37802188
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of hepatocellular carcinoma in Italy.
Stroffolini T; Andreone P; Andriulli A; Ascione A; Craxi A; Chiaramonte M; Galante D; Manghisi OG; Mazzanti R; Medaglia C; Pilleri G; Rapaccini GL; Simonetti RG; Taliani G; Tosti ME; Villa E; Gasbarrini G
J Hepatol; 1998 Dec; 29(6):944-52. PubMed ID: 9875641
[TBL] [Abstract][Full Text] [Related]
16. High incidence of hepatocellular carcinoma and postoperative complications in patients with nonalcoholic steatohepatitis as a primary indication for deceased liver transplantation.
Kern B; Feurstein B; Fritz J; Fabritius C; Sucher R; Graziadei I; Bale R; Tilg H; Zoller H; Newsome P; Eschertzhuber S; Margreiter R; Öfner D; Schneeberger S
Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):205-210. PubMed ID: 30320609
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma in southern Germany: epidemiological and clinicopathological characteristics and risk factors.
Hellerbrand C; Hartmann A; Richter G; Knöll A; Wiest R; Schölmerich J; Lock G
Dig Dis; 2001; 19(4):345-51. PubMed ID: 11935095
[TBL] [Abstract][Full Text] [Related]
18. Risk and outcome of hepatocellular carcinoma in liver cirrhosis in Southern Sweden: a population-based study.
Nilsson E; Anderson H; Sargenti K; Lindgren S; Prytz H
Scand J Gastroenterol; 2019 Aug; 54(8):1027-1032. PubMed ID: 31389730
[No Abstract] [Full Text] [Related]
19. Hepatocellular carcinoma in western Sydney. Aetiology, changes in incidence, and opportunities for better outcomes.
Brotodihardjo AE; Tait N; Weltman MD; Liddle C; Little JM; Farrell GC
Med J Aust; 1994 Oct; 161(7):433-5. PubMed ID: 7935098
[TBL] [Abstract][Full Text] [Related]
20. Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development.
Benvegnù L; Noventa F; Bernardinello E; Pontisso P; Gatta A; Alberti A
Gut; 2001 Jan; 48(1):110-5. PubMed ID: 11115831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
